PortfoliosLab logoPortfoliosLab logo
HEAW.L vs. WBIO.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HEAW.L vs. WBIO.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in SPDR MSCI World Health Care UCITS ETF (HEAW.L) and WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

HEAW.L is traded in GBP, while WBIO.L is traded in GBp. To make them comparable, the WBIO.L values have been converted to GBP using the latest available exchange rates.

Returns By Period

In the year-to-date period, HEAW.L achieves a -2.73% return, which is significantly lower than WBIO.L's 10.42% return.


HEAW.L

1D
3.01%
1M
4.33%
YTD
-2.73%
6M
-2.25%
1Y
12.68%
3Y*
2.71%
5Y*
10Y*

WBIO.L

1D
4.36%
1M
4.49%
YTD
10.42%
6M
10.40%
1Y
50.88%
3Y*
1.10%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HEAW.L vs. WBIO.L - Yearly Performance Comparison


2026 (YTD)2025202420232022
HEAW.L
SPDR MSCI World Health Care UCITS ETF
-2.73%7.46%2.52%-2.05%5.82%
WBIO.L
WisdomTree BioRevolution UCITS ETF USD Acc
10.42%13.58%-14.08%-5.86%-9.25%

Correlation

The correlation between HEAW.L and WBIO.L is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.56

Correlation (3Y)
Calculated over the trailing 3-year period

0.51

Correlation (All Time)
Calculated using the full available price history since Apr 5, 2022

0.56

The correlation between HEAW.L and WBIO.L has been stable across timeframes, ranging from 0.51 to 0.56 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HEAW.L vs. WBIO.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HEAW.L
HEAW.L Risk / Return Rank: 2525
Overall Rank
HEAW.L Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
HEAW.L Sortino Ratio Rank: 2727
Sortino Ratio Rank
HEAW.L Omega Ratio Rank: 2525
Omega Ratio Rank
HEAW.L Calmar Ratio Rank: 2525
Calmar Ratio Rank
HEAW.L Martin Ratio Rank: 2424
Martin Ratio Rank

WBIO.L
WBIO.L Risk / Return Rank: 6161
Overall Rank
WBIO.L Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
WBIO.L Sortino Ratio Rank: 5555
Sortino Ratio Rank
WBIO.L Omega Ratio Rank: 5151
Omega Ratio Rank
WBIO.L Calmar Ratio Rank: 8383
Calmar Ratio Rank
WBIO.L Martin Ratio Rank: 5959
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HEAW.L vs. WBIO.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR MSCI World Health Care UCITS ETF (HEAW.L) and WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HEAW.LWBIO.LDifference
Sharpe ratioReturn per unit of total volatility

-0.99

Sortino ratioReturn per unit of downside risk

-1.18

Omega ratioGain probability vs. loss probability

1.17

1.31

-0.15

Calmar ratioReturn relative to maximum drawdown

1.18

4.40

-3.22

Martin ratioReturn relative to average drawdown

3.10

10.38

-7.28

HEAW.L vs. WBIO.L - Sharpe Ratio Comparison

The current HEAW.L Sharpe Ratio is 0.92, which is lower than the WBIO.L Sharpe Ratio of 1.91. The chart below compares the historical Sharpe Ratios of HEAW.L and WBIO.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


HEAW.LWBIO.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.92

1.91

-0.99

Sharpe Ratio (All Time)

Calculated using the full available price history

0.20

-0.19

+0.39

Drawdowns

HEAW.L vs. WBIO.L - Drawdown Comparison

The maximum HEAW.L drawdown since its inception was -18.85%, smaller than the maximum WBIO.L drawdown of -51.13%. Use the drawdown chart below to compare losses from any high point for HEAW.L and WBIO.L.


Loading charts...

Drawdown Indicators


HEAW.LWBIO.LDifference

Max Drawdown

Largest peak-to-trough decline

-18.85%

-51.13%

+32.28%

Max Drawdown (1Y)

Largest decline over 1 year

-10.71%

-11.50%

+0.79%

Max Drawdown (3Y)

Largest decline over 3 years

-18.85%

-39.34%

+20.49%

Current Drawdown

Current decline from peak

-6.00%

-18.76%

+12.76%

Average Drawdown

Average peak-to-trough decline

-5.60%

-26.35%

+20.75%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.08%

4.89%

-0.81%

Volatility

HEAW.L vs. WBIO.L - Volatility Comparison

The current volatility for SPDR MSCI World Health Care UCITS ETF (HEAW.L) is 5.19%, while WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) has a volatility of 6.84%. This indicates that HEAW.L experiences smaller price fluctuations and is considered to be less risky than WBIO.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HEAW.LWBIO.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.19%

6.84%

-1.65%

Volatility (6M)

Calculated over the trailing 6-month period

9.96%

17.06%

-7.10%

Volatility (1Y)

Calculated over the trailing 1-year period

13.70%

26.57%

-12.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

13.11%

23.70%

-10.59%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

13.11%

23.70%

-10.59%

HEAW.L vs. WBIO.L - Expense Ratio Comparison

HEAW.L has a 0.30% expense ratio, which is lower than WBIO.L's 0.45% expense ratio.


Dividends

HEAW.L vs. WBIO.L - Dividend Comparison

Neither HEAW.L nor WBIO.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


HEAW.L and WBIO.L have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, HEAW.L is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.

HEAW.L is cheaper with a 0.30% expense ratio, compared with 0.45% for WBIO.L.

HEAW.L tracks MSCI World/Health Care NR USD, while WBIO.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: State Street and WisdomTree. Their fees differ too: 0.30% for HEAW.L and 0.45% for WBIO.L.

Portfolio Optimizer

Find the right allocation for HEAW.L and WBIO.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer